Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Is Alzheimer's disease a type 3 diabetes? A review

J. Janoutová, O. Machaczka, A. Zatloukalová, V. Janout

. 2022 ; 30 (3) : 139-143. [pub] 20220930

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc22026970

Digitální knihovna NLK
Zdroj

E-zdroje Online Plný text

NLK Free Medical Journals od 2004
ProQuest Central od 2009-03-01 do Před 6 měsíci
Medline Complete (EBSCOhost) od 2006-03-01 do Před 6 měsíci
Nursing & Allied Health Database (ProQuest) od 2009-03-01 do Před 6 měsíci
Health & Medicine (ProQuest) od 2009-03-01 do Před 6 měsíci
Public Health Database (ProQuest) od 2009-03-01 do Před 6 měsíci
ROAD: Directory of Open Access Scholarly Resources od 1993

OBJECTIVES: This is a review article that deals with the question of whether type 2 diabetes is a risk factor for the development of Alzheimer's disease. METHODS: We searched the PubMed database and relevant publications were selected for review. The introduction, which describes the possibilities of how type 2 diabetes can affect the development of Alzheimer's disease, is followed by other questions related to this issue: May on the contrary Alzheimer's disease induce type 2 diabetes? What is a relative risk for type 2 diabetes to induce dementia? How type 2 diabetes influence conversion of mild cognitive impairment to Alzheimer's disease? What is the role of antidiabetic medication? Proposition of term "type 3 diabetes" for Alzheimer's disease. RESULTS: Type 2 diabetes mellitus has been shown to increase the risk for cognitive decline and dementia, such as Alzheimer's disease and vascular dementia. Despite extensive research and numerous publications, the mechanisms underlying these associations remain unclear. CONCLUSIONS: Because of similar molecular and cellular features among type 1 and type 2 diabetes and insulin resistance associated with memory deficit and cognitive decline, some researches proposed the term "type 3 diabetes" for Alzheimer's disease.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22026970
003      
CZ-PrNML
005      
20230313115037.0
007      
ta
008      
221108s2022 xr f 000 0|eng||
009      
AR
024    7_
$a 10.21101/cejph.a7238 $2 doi
035    __
$a (PubMed)36239360
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Janoutová, Jana $u Faculty of Medicine, Palacky University in Olomouc, Olomouc, Czech Republic $7 xx0224262
245    10
$a Is Alzheimer's disease a type 3 diabetes? A review / $c J. Janoutová, O. Machaczka, A. Zatloukalová, V. Janout
520    9_
$a OBJECTIVES: This is a review article that deals with the question of whether type 2 diabetes is a risk factor for the development of Alzheimer's disease. METHODS: We searched the PubMed database and relevant publications were selected for review. The introduction, which describes the possibilities of how type 2 diabetes can affect the development of Alzheimer's disease, is followed by other questions related to this issue: May on the contrary Alzheimer's disease induce type 2 diabetes? What is a relative risk for type 2 diabetes to induce dementia? How type 2 diabetes influence conversion of mild cognitive impairment to Alzheimer's disease? What is the role of antidiabetic medication? Proposition of term "type 3 diabetes" for Alzheimer's disease. RESULTS: Type 2 diabetes mellitus has been shown to increase the risk for cognitive decline and dementia, such as Alzheimer's disease and vascular dementia. Despite extensive research and numerous publications, the mechanisms underlying these associations remain unclear. CONCLUSIONS: Because of similar molecular and cellular features among type 1 and type 2 diabetes and insulin resistance associated with memory deficit and cognitive decline, some researches proposed the term "type 3 diabetes" for Alzheimer's disease.
650    12
$a Alzheimerova nemoc $x komplikace $x epidemiologie $7 D000544
650    12
$a kognitivní dysfunkce $x komplikace $x epidemiologie $7 D060825
650    12
$a diabetes mellitus $7 D003920
650    _2
$a diabetes mellitus 2. typu $x komplikace $x epidemiologie $7 D003924
650    _2
$a lidé $7 D006801
650    _2
$a hypoglykemika $x terapeutické užití $7 D007004
650    _2
$a rizikové faktory $7 D012307
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Machaczka, Ondřej $u Faculty of Health Sciences, Palacky University in Olomouc, Olomouc, Czech Republic $7 xx0224260
700    1_
$a Zatloukalová, Anna $u Faculty of Health Sciences, Palacky University in Olomouc, Olomouc, Czech Republic $7 xx0224265
700    1_
$a Janout, Vladimír, $u Faculty of Health Sciences, Palacky University in Olomouc, Olomouc, Czech Republic $d 1939- $7 jn20010524003
773    0_
$w MED00001083 $t Central European journal of public health $x 1210-7778 $g Roč. 30, č. 3 (2022), s. 139-143
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36239360 $y Pubmed
910    __
$a ABA008 $b B 1829 $c 562 $y p $z 0
990    __
$a 20221108 $b ABA008
991    __
$a 20230313115035 $b ABA008
999    __
$a ok $b bmc $g 1896147 $s 1178277
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 30 $c 3 $d 139-143 $e 20220930 $i 1210-7778 $m Central European Journal of Public Health $n Cent. Eur. J. Public Health $x MED00001083
LZP    __
$b NLK198 $a Pubmed-20221108

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...